Targeted Delivery of BMS-1166 for Enhanced Breast Cancer Immunotherapy
These results provide preliminary evidence indicating that BMS-T7 may have the potential to deliver drugs to breast cancer cells via active targeting and hold great promise in cancer immunotherapy drug delivery applications.
Authors
- Yunqi Zhao (ORCID: https://orcid.org/0000-0001-5471-6125)
- Zhecheng Yu (ORCID: https://orcid.org/0009-0001-2768-118X)
- Zheng‐Yi Zhou (ORCID: https://orcid.org/0000-0001-9014-8479)
Institutions
- Wenzhou-Kean University (CN)
- Kean University (US)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.2147/ijn.s497089
- Citations
- 7
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 4.72
Funders
- Natural Science Foundation of Zhejiang Province